US Stock MarketDetailed Quotes

GELS Gelteq

Watchlist
  • 1.640
  • -0.180-9.89%
Close Feb 28 16:00 ET
  • 1.640
  • 0.0000.00%
Post 16:41 ET
15.48MMarket Cap-7.01P/E (TTM)

About Gelteq Company

Gelteq Ltd. is a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.

Company Profile

SymbolGELS
Company NameGelteq
Listing DateOct 29, 2024
Issue Price4.00
Founded2017
CEOMr. Nathan J. Givoni
MarketNASDAQ
Employees20
Fiscal Year Ends06-30
Address100 Albert Road,Level 4
CitySouth Melbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3025
Phone61-3-9087-3990

Company Executives

  • Name
  • Position
  • Salary
  • Nathan J. Givoni
  • Director and Chief Executive Officer
  • --
  • Anthony W. Panther
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Simon H. Szewach
  • Executive Chairman of the Board
  • --
  • Jeffrey W. Olyniec
  • Independent Director
  • --
  • The Honourable Philip A. Dalidakis
  • Independent Director
  • --
  • Professor David Morton
  • Independent Director
  • --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.